Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis

Author:

Darzi Andrea J.12ORCID,Karam Samer G.12ORCID,Charide Rana3,Etxeandia-Ikobaltzeta Itziar12,Cushman Mary45ORCID,Gould Michael K.6,Mbuagbaw Lawrence1278ORCID,Spencer Frederick A.9,Spyropoulos Alex C.10,Streiff Michael B.11ORCID,Woller Scott12ORCID,Zakai Neil A.45,Germini Federico12913ORCID,Rigoni Marta14ORCID,Agarwal Arnav1215,Morsi Rami Z.3ORCID,Iorio Alfonso129ORCID,Akl Elie A.12316,Schünemann Holger J.129ORCID

Affiliation:

1. Michael G. DeGroote Cochrane Canada and

2. McMaster GRADE (Grading of Recommendations Assessment, Development, and Evaluation) Centres, Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada;

3. American University of Beirut (AUB) GRADE Center, Clinical Research Institute, American University of Beirut, Beirut, Lebanon;

4. Department of Medicine and

5. Department of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, VT;

6. Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA;

7. Biostatistics Unit, Father Sean O'Sullivan Research Centre, St Joseph’s Healthcare, Hamilton, ON, Canada;

8. Centre for Development of Best Practices in Health (CDBPH), Yaoundé Central Hospital, Yaoundé, Cameroon;

9. Department of Medicine; McMaster University; Hamilton, ON, Canada;

10. The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Medicine, Northwell Health at Lenox Hill Hospital, Manhasset, NY;

11. Division of Hematology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD;

12. Department of Medicine, Intermountain Medical Center, University of Utah School of Medicine, Salt Lake City, UT;

13. Department of Health Sciences, Università degli Studi di Milano, Milan, Italy;

14. Healthcare Research and Innovation Program, Heath Technology Assessment Unit, Fondazione Bruno Kessler, Trento, Italy;

15. Faculty of Medicine, University of Toronto, Toronto, ON, Canada; and

16. Department of Internal Medicine, AUB, Beirut, Lebanon

Abstract

Abstract There may be many predictors of venous thromboembolism (VTE) and bleeding in hospitalized medical patients, but until now, systematic reviews and assessments of the certainty of the evidence have not been published. We conducted a systematic review to identify prognostic factors for VTE and bleeding in hospitalized medical patients and searched Medline and EMBASE from inception through May 2018. We considered studies that identified potential prognostic factors for VTE and bleeding in hospitalized adult medical patients. Reviewers extracted data in duplicate and independently and assessed the certainty of the evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach. Of 69 410 citations, we included 17 studies in our analysis: 14 that reported on VTE, and 3 that reported on bleeding. For VTE, moderate-certainty evidence showed a probable association with older age; elevated C-reactive protein (CRP), D-dimer, and fibrinogen levels; tachycardia; thrombocytosis; leukocytosis; fever; leg edema; lower Barthel Index (BI) score; immobility; paresis; previous history of VTE; thrombophilia; malignancy; critical illness; and infections. For bleeding, moderate-certainty evidence showed a probable association with older age, sex, anemia, obesity, low hemoglobin, gastroduodenal ulcers, rehospitalization, critical illness, thrombocytopenia, blood dyscrasias, hepatic disease, renal failure, antithrombotic medication, and presence of a central venous catheter. Elevated CRP, a lower BI, a history of malignancy, and elevated heart rate are not included in most VTE risk assessment models. This study informs risk prediction in the management of hospitalized medical patients for VTE and bleeding; it also informs guidelines for VTE prevention and future research.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3